Onkologie. 2016:10(2):62-65 | DOI: 10.36290/xon.2016.015

Basal cell carcinoma

Petr Arenberger, Jiří Ettler
Dermatovenerologická klinika 3. LF Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha

Basal cell carcinoma is a malignant epidermal tumour arising from the basal cell layer. It grows slowly, but destroys the skin as well

as surrounding tissue in the site area. However, it has an extremely low risk of metastasis. Basal cell carcinoma has a characteristic

clinical and histological presentation. Treatment options include surgical resection, curettage, cryotherapy, diathermocoagulation,

local immunotherapy, photodynamic therapy, targeted systemic therapy, and radiotherapy. Some of them are discussed in

detail in the present article.

Keywords: basal cell carcinoma, clinical presentation, treatment

Published: May 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Arenberger P, Ettler J. Basal cell carcinoma. Onkologie. 2016;10(2):62-65. doi: 10.36290/xon.2016.015.
Download citation

References

  1. Alter M, Hillen U, Leiter U, Sachse M, Gutzmer R. Current diagnosis and treatment of basal cell carcinoma. J Dtsch Dermatol Ges. 2015 Sep;13(9):863-75. doi: 10.1111/ddg.12798. Go to original source... Go to PubMed...
  2. Burness CB, Scott LJ. Sonidegib: A Review in Locally Advanced Basal Cell Carcinoma. Target Oncol. 2016 Feb 12. [Epub ahead of print]. Go to original source... Go to PubMed...
  3. Griffin LL, Ali FR, Lear JT. Non-melanoma skin cancer. Clin Med (Lond). 2016 Feb; 16(1): 62-65. doi: 10.7861/clinmedicine.16-1-62. Go to original source... Go to PubMed...
  4. Karagas MR, Stukel TA, Greenberg ER, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 267, 1992; (24): 3305-10. Go to original source...
  5. Kiiski V, de Vries E, Flohil SC, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010; 146(8): 848-855. Go to original source... Go to PubMed...
  6. Robinson JK. Risk of developing another basal cell carcinoma. A 5-year prospective study. Cancer 1987; 60(1): 118-120. Go to original source...
  7. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15 (3): 315-328. Go to original source... Go to PubMed...
  8. Tarstedt M, Gillstedt M, Wennberg Larkö AM, Paoli J. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers. J Eur Acad Dermatol Venereol. 2016 Feb 3. doi: 10.1111/jdv.13558. [Epub ahead of print]. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.